151 related articles for article (PubMed ID: 2523002)
21. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
[TBL] [Abstract][Full Text] [Related]
22. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
23. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers.
Hsu HM; Chen DS; Chuang CH; Lu JC; Jwo DM; Lee CC; Lu HC; Cheng SH; Wang YF; Wang CY
JAMA; 1988 Oct; 260(15):2231-5. PubMed ID: 2971827
[TBL] [Abstract][Full Text] [Related]
25. [Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].
Palmović D; Vitas B; Doko A; Belavić Z; Racki L
Lijec Vjesn; 1989 Nov; 111(11):400-4. PubMed ID: 2534601
[TBL] [Abstract][Full Text] [Related]
26. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
27. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
28. Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus.
McMahon BJ; Bender TR; Berquist KR; Schreeder MT; Harpster AP
J Clin Microbiol; 1981 Aug; 14(2):130-4. PubMed ID: 7276146
[TBL] [Abstract][Full Text] [Related]
29. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination.
Collier AC; Corey L; Murphy VL; Handsfield HH
Ann Intern Med; 1988 Jul; 109(2):101-5. PubMed ID: 2968064
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of hepatitis B in two Alaska communities.
Barrett DH; Burks JM; McMahon B; Elliott S; Berquist KR; Bender TR; Maynard JE
Am J Epidemiol; 1977 Feb; 105(2):118-22. PubMed ID: 835563
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs.
Lok AS; Lai CL; Wu PC
Hepatology; 1988; 8(4):766-70. PubMed ID: 2968945
[TBL] [Abstract][Full Text] [Related]
32. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
Frazer IH; Jones B; Dimitrakakis M; Mackay IR
Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
[TBL] [Abstract][Full Text] [Related]
33. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
[TBL] [Abstract][Full Text] [Related]
34. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area.
Esteban JI; Genesca J; Esteban R; Hernandez JM; Seijo G; Buti M; Muniz R; Guardia J
J Med Virol; 1986 Apr; 18(4):381-91. PubMed ID: 2940334
[TBL] [Abstract][Full Text] [Related]
35. Increases in levels of antibody to hepatitis B surface antigen in an immunized population.
Bulkow LR; Wainwright RB; McMahon BJ; Parkinson AJ
Clin Infect Dis; 1998 Apr; 26(4):933-7. PubMed ID: 9564478
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives.
McMahon BJ; Schoenberg S; Bulkow L; Wainwright RB; Fitzgerald MA; Parkinson AJ; Coker E; Ritter D
Am J Epidemiol; 1993 Oct; 138(7):544-9. PubMed ID: 8213758
[TBL] [Abstract][Full Text] [Related]
37. A combined vaccine against hepatitis A and B in children and adolescents.
Diaz-Mitoma F; Law B; Parsons J
Pediatr Infect Dis J; 1999 Feb; 18(2):109-14. PubMed ID: 10048681
[TBL] [Abstract][Full Text] [Related]
38. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen.
McMahon BJ; Parkinson AJ; Helminiak C; Wainwright RB; Bulkow L; Kellerman-Douglas A; Schoenberg S; Ritter D
Gastroenterology; 1992 Aug; 103(2):590-4. PubMed ID: 1386048
[TBL] [Abstract][Full Text] [Related]
39. Immune responses of prematurely born infants to hepatitis B vaccination: results through three years of age.
Kesler K; Nasenbeny J; Wainwright R; McMahon B; Bulkow L
Pediatr Infect Dis J; 1998 Feb; 17(2):116-9. PubMed ID: 9493806
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
